Research Advancement of Toll-like Receptor 7 in Atherosclerosis
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Toll-like receptor 7 (TLR7),a type Ⅰ transmembrane protein receptor expressed in mammalian cells,has the same structure characters and similar functions as other members of TLR family.In addition to regulating some immune responses induced by virus through the MyD88-dependent signaling pathway,TLR7 can adjust the autophagy of macrophages to mediate the progress of atherosclerosis.Furthermore,it is probably to not only induce the type Ⅰ interferon expression,but also act as autoantigens to activate cellular and humoral immune response mediated by T cells and B cells by all kinds of ligand and endogenous molecules,thus participate in regulating the development of atherosclerosis.Therefore,it is critical that more attention is given to the function and mechanism research of TLR7 in atherosclerosis,which will be a new starting point for the prevention and control of atherosclerosis.

    Reference
    Related
    Cited by
Get Citation

HUANG Wei-Jun, HUANG Yu-Li, and HU Yun-Zhao. Research Advancement of Toll-like Receptor 7 in Atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2015,23(07):740-743.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 16,2014
  • Revised:
  • Adopted:
  • Online: July 03,2015
  • Published:
Article QR Code